作者
N Arulkumaran, LJBP Lightstone
发表日期
2013/12/1
来源
Best Practice & Research Clinical Obstetrics & Gynaecology
卷号
27
期号
6
页码范围
877-884
出版商
Baillière Tindall
简介
Hypertensive disorders of pregnancy are one of the leading causes of peripartum morbidity and mortality globally. Hypertensive disease in pregnancy is associated with a spectrum of severity, ranging from mild pregnancy-induced hypertension to eclampsia. Although most cases of pre-eclampsia may be managed successfully, severe pre-eclampsia is a life-threatening multisystem disease associated with eclampsia, HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome, acute kidney injury, pulmonary oedema, placental abruption and intrauterine foetal death. Management of severe pre-eclampsia includes identification of high-risk patients, optimisation of antenatal care, early intervention and the identification and early management of complications. In the first instance, oral anti-hypertensive agents, including labetalol, nifedipine and methyldopa, should be tried. If oral anti-hypertensive agents have …
引用总数
20142015201620172018201920202021202220232024102420192721191720135
学术搜索中的文章
N Arulkumaran, L Lightstone - Best Practice & Research Clinical Obstetrics & …, 2013